Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • M.D., University of Texas, Medical Branch at Galveston 1995
• 

  Duke Appointment History

  • Assistant Professor in Community and Family Medicine, Community and Family Medicine, Physician Assistant Program, Community and Family Medicine 2009 - 2013
  • Assistant Professor of Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, General Psychiatry, Psychiatry & Behavioral Sciences 2008 - 2012
  • Clinical Associate in the Department of Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, General Psychiatry, Psychiatry & Behavioral Sciences 2006 - 2008
• Recognition
• 

  In the News

  • NOV 7, 2013

    News 14

    Duke University unveils airport safety research
• Research
• 

  Selected Grants

  • DS-5565-E312 in Subjects with Pain Associated with Fibromyalgia awarded by Daiichi Sankyo Co Ltd 2015 - 2019
  • DS-5565 in Subjects with Pain Associated with Fibromyalgia awarded by Daiichi Sankyo Co Ltd 2015 - 2018
• Publications & Artistic Works
• 

  Selected Publications

  • Journal Articles

    • Lin, KA, Choudhury, KR, Rathakrishnan, BG, Marks, DM, Petrella, JR, Doraiswamy, PM, and Alzheimer's Disease Neuroimaging Initiative, . "Marked gender differences in progression of mild cognitive impairment over 8 years." Alzheimer's & dementia (New York, N. Y.) 1, no. 2 (September 2015): 103-110.  Full Text
    • Marks, DM, and Newhouse, A. "Durability of Benefit From Repeated Intravenous Lidocaine Infusions in Fibromyalgia Patients: A Case Series and Literature Review." The primary care companion for CNS disorders 17, no. 5 (January 2015).  Full Text
    • Marks, DM, Pae, C-U, and Patkar, AA. "A double-blind, placebo-controlled, parallel-group pilot study of milnacipran for chronic radicular pain (sciatica) associated with lumbosacral disc disease." The primary care companion for CNS disorders 16, no. 4 (January 2014).  Full Text
    • Kim, JL, Rele, S, Marks, DM, Masand, PS, Yerramsetty, P, Millet, RA, Keefe, RS, and Patkar, AA. "Effects of milnacipran on neurocognition, pain, and fatigue in fibromyalgia: a 13-week, randomized, placebo-controlled, crossover trial." The primary care companion for CNS disorders 15, no. 6 (January 2013).  Full Text
    • Marks, DM, and Bolognesi, MP. "Open-label milnacipran for patients with persistent knee pain 1 year or longer after total knee arthroplasty: A pilot study." Primary Care Companion to the Journal of Clinical Psychiatry 15, no. 4 (2013).  Full Text
    • Marks, DM, Abramowitz, JS, and Spielmans, GI. "Concerns about data reporting and interpretation in " Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial"." Journal of Psychiatric Research 46, no. 5 (2012): 692-693.  Full Text
    • Marks, DM. "Amitifadine hydrochloride: Triple reuptake inhibitor treatment of depression." Drugs of the Future 37, no. 4 (January 1, 2012): 241-246. (Review)  Full Text
    • Marks, DM. "Amitifadine hydrochloride: Triple reuptake inhibitor treatment of depression." Drugs of the Future 37, no. 4 (2012): 241-246.  Full Text
    • Hardy, TA, Henry, RR, Forrester, TD, Kryzhanovskaya, LA, Campbell, GM, Marks, DM, and Mudaliar, S. "Impact of olanzapine or risperidone treatment on insulin sensitivity in schizophrenia or schizoaffective disorder." Diabetes, Obesity and Metabolism 13, no. 8 (2011): 726-735.  Full Text
    • Marks, DM, Shah, MJ, Patkar, AA, Masand, PS, Park, G-Y, and Pae, C-U. "Serotonin-norepinephrine reuptake inhibitors for pain control: premise and promise." Curr Neuropharmacol 7, no. 4 (December 2009): 331-336.  Full Text  Link to Item
    • Pae, C-U, Tharwani, H, Marks, DM, Masand, PS, and Patkar, AA. "Atypical depression: a comprehensive review." CNS Drugs 23, no. 12 (December 2009): 1023-1037. (Review)  Full Text  Link to Item
    • Pae, C-U, Marks, DM, Shah, M, Han, C, Ham, B-J, Patkar, AA, and Masand, PS. "Milnacipran: beyond a role of antidepressant." Clin Neuropharmacol 32, no. 6 (November 2009): 355-363. (Review)  Full Text  Link to Item
    • Pae, C-U, Masand, PS, Marks, DM, Krulewicz, S, Peindl, K, Mannelli, P, and Patkar, AA. "History of depressive and/or anxiety disorders as a predictor of treatment response: a post hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release in patients with fibromyalgia." Prog Neuropsychopharmacol Biol Psychiatry 33, no. 6 (August 31, 2009): 996-1002.  Full Text  Link to Item
    • Pae, C-U, Marks, DM, Patkar, AA, Masand, PS, Luyten, P, and Serretti, A. "Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants." Expert Opin Pharmacother 10, no. 10 (July 2009): 1561-1570. (Review)  Full Text  Link to Item
    • Marks, DM, Patkar, AA, Masand, PS, and Pae, C-U. "Does pregabalin have neuropsychotropic effects?: a short perspective." Psychiatry Investig 6, no. 2 (June 2009): 55-58.  Full Text  Link to Item
    • Marks, DM, Conner, MJ, and Pae, C-U. "Safety and antipsychotic efficacy of "forced" intramuscular olanzapine over five days: a case report." Prog Neuropsychopharmacol Biol Psychiatry 33, no. 2 (March 17, 2009): 386-387. (Letter)  Full Text  Link to Item
    • Han, C, Kwak, K-P, Marks, DM, Pae, C-U, Wu, L-T, Bhatia, KS, Masand, PS, and Patkar, AA. "The impact of the CONSORT statement on reporting of randomized clinical trials in psychiatry." Contemp Clin Trials 30, no. 2 (March 2009): 116-122.  Full Text  Link to Item
    • Marks, DM, J, T, and Pae, C-U. "Innovations in clinical research design and conduct in psychiatry: shifting to pragmatic approaches." Psychiatry Investig 6, no. 1 (March 2009): 1-6.  Full Text  Link to Item
    • Pae, C-U, Mandelli, L, Kim, T-S, Han, C, Masand, PS, Marks, DM, Patkar, AA, Steffens, DC, De Ronchi, D, and Serretti, A. "Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: a pilot study on differential effects of sex hormones on antidepressant effects." Biomed Pharmacother 63, no. 3 (March 2009): 228-235.  Full Text  Link to Item
    • Pae, C-U, Marks, DM, Masand, PS, Peindl, K, Hooper-Wood, C, Han, C, Mannelli, P, Ciccone, P, and Patkar, AA. "Methylphenidate extended release (OROS MPH) for the treatment of antidepressant-related sexual dysfunction in patients with treatment-resistant depression: results from a 4-week, double-blind, placebo-controlled trial." Clin Neuropharmacol 32, no. 2 (March 2009): 85-88.  Full Text  Link to Item
    • Pae, C-U, Marks, DC, Han, C, Patkar, AA, and Masand, PS. "Duloxetine: an emerging evidence for fibromyalgia." Biomed Pharmacother 63, no. 1 (January 2009): 69-71. (Letter)  Full Text  Link to Item
    • Pae, C-U, Marks, DM, Han, C, Masand, PS, and Patkar, AA. "Pregabalin augmentation of antidepressants in patients with accident-related posttraumatic stress disorder: an open label pilot study." Int Clin Psychopharmacol 24, no. 1 (January 2009): 29-33.  Full Text  Link to Item
    • Pae, C-U, Masand, PS, Marks, DM, Krulewicz, S, Han, C, Peindl, K, Mannelli, P, and Patkar, AA. "History of early abuse as a predictor of treatment response in patients with fibromyalgia: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release." World J Biol Psychiatry 10, no. 4 Pt 2 (2009): 435-441.  Full Text  Link to Item
    • Pae, C-U, Park, M-H, Marks, DM, Han, C, Patkar, AA, and Masand, PS. "Desvenlafaxine, a serotonin-norepinephrine uptake inhibitor for major depressive disorder, neuropathic pain and the vasomotor symptoms associated with menopause." Curr Opin Investig Drugs 10, no. 1 (January 2009): 75-90.  Link to Item
    • Marks, DM, Pae, C-U, and Patkar, AA. "Triple reuptake inhibitors: the next generation of antidepressants." Curr Neuropharmacol 6, no. 4 (December 2008): 338-343.  Full Text  Link to Item
    • Marks, DM, Park, M-H, Ham, B-J, Han, C, Patkar, AA, Masand, PS, and Pae, C-U. "Paroxetine: safety and tolerability issues." Expert Opin Drug Saf 7, no. 6 (November 2008): 783-794. (Review)  Full Text  Link to Item
    • Pae, C-U, Marks, DM, Han, C, Patkar, AA, and Steffens, D. "Does neurotropin-3 have a therapeutic implication in major depression?." Int J Neurosci 118, no. 11 (November 2008): 1515-1522. (Review)  Full Text  Link to Item
    • Marks, DM, Pae, C-U, and Patkar, AA. "Triple reuptake inhibitors: a premise and promise." Psychiatry Investig 5, no. 3 (September 2008): 142-147.  Full Text  Link to Item
    • Marks, DM, Pae, C-U, and Patkar, AA. "Potential role of pregabalin in the treatment of lithium-induced tremor: a case report." Int J Neuropsychopharmacol 11, no. 6 (September 2008): 879-881. (Letter)  Full Text  Link to Item
    • Pae, C-U, Marks, DM, Han, C, Patkar, AA, and Masand, P. "Delirium: underrecognized and undertreated." Curr Treat Options Neurol 10, no. 5 (September 2008): 386-395.  Link to Item
    • Pae, C-U, Luyten, P, Marks, DM, Han, C, Park, S-H, Patkar, AA, Masand, PS, and Van Houdenhove, B. "The relationship between fibromyalgia and major depressive disorder: a comprehensive review." Curr Med Res Opin 24, no. 8 (August 2008): 2359-2371. (Review)  Full Text  Link to Item
    • Pae, C-U, Marks, DM, Han, C, Patkar, AA, and Masand, P. "Delirium: where do we stand?." Curr Psychiatry Rep 10, no. 3 (June 2008): 240-248. (Review)  Link to Item
    • Pae, C-U, Marks, DM, Han, C, and Patkar, AA. "Does minocycline have antidepressant effect?." Biomed Pharmacother 62, no. 5 (June 2008): 308-311.  Full Text  Link to Item
    • Pae, C-U, Marks, DM, Han, C, and Patkar, AA. "A case of transient hallucination with ropinirole augmentation antidepressant in a patient with treatment-resistant depression: Is there differential effect of ropinirole dose on developing psychotic symptom?." Prog Neuropsychopharmacol Biol Psychiatry 32, no. 4 (May 15, 2008): 1087-1088. (Letter)  Full Text  Link to Item
    • Pae, C-U, Han, C, Marks, DM, and Patkar, AA. "Comments on "Addition of lamotrigine to valproic acid: a successful outcome in a case of rapid-cycling bipolar affective disorder"." Prog Neuropsychopharmacol Biol Psychiatry 32, no. 2 (February 15, 2008): 595-596. (Letter)  Full Text  Link to Item
    • Han, C, Marks, DM, Pae, C-U, Lee, BH, Ko, Y-H, Masand, PS, Patkar, AA, and Jung, I-K. "Paroxetine for patients with undifferentiated somatoform disorder: A prospective, open-label, 8-week pilot study." Current Therapeutic Research - Clinical and Experimental 69, no. 3 (2008): 221-231.  Full Text
    • Marks, DM, Han, C, Krulewicz, S, Pae, C-U, Peindl, K, Patkar, AA, and Masand, PS. "History of depressive and anxiety disorders and paroxetine response in patients with irritable bowel syndrome: post hoc analysis from a placebo-controlled study." Prim Care Companion J Clin Psychiatry 10, no. 5 (2008): 368-375.  Link to Item
    • Pae, C-U, Masand, PS, Peindl, K, Mannelli, P, Han, C, Marks, DM, and Patkar, AA. "An open-label, rater-blinded, flexible-dose, 8-week trial of escitalopram in patients with major depressive disorder with atypical features." Prim Care Companion J Clin Psychiatry 10, no. 3 (2008): 205-210.  Link to Item
    • Ziran, BH, Wasan, AD, Marks, DM, Olson, SA, and Chapman, MW. "Fluoroscopic imaging guides of the posterior pelvis pertaining to iliosacral screw placement." J Trauma 62, no. 2 (February 2007): 347-356.  Full Text  Link to Item
    • Vieta, E, Calabrese, JR, Goikolea, JM, Raines, S, Macfadden, W, Alam, M, Arnold, V, Bailey, C, Brannon, G, Brown, D, Calabrese, J, Carman, J, Cutler, A, D'Souza, B, Emmanuel, N, Ginsberg, L, Gopalan, R, Granger, W, Gyulai, L, Hassman, H, Helfing, S, Joseph, G, Keck, P, Ketter, T, Khan, A, Kiev, A, Kolin, I, Knutson, J, Levy, M, Logue, HE, Marks, D, Mattingly, G, Merideth, C, Miller, J, Munjack, D, Privitera, W, Reimherr, F, Riesenberg, R, Rosenberg, L, Rubenfaer, L, Sack, D, and Strauss, A et al. "Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: A randomized, double-blind, placebo-controlled study." Bipolar Disorders 9, no. 4 (2007): 413-425.  Full Text
    • Ingels, M, Marks, D, and Clark, RF. "A survey of medical toxicology training in psychiatry residency programs." Academic Psychiatry 27, no. 1 (2003): 50-53.  Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.